{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:46:29Z","timestamp":1785296789350,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2016R1A2B4011333"],"award-info":[{"award-number":["NRF-2016R1A2B4011333"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2018R1A6A1A03025108"],"award-info":[{"award-number":["NRF-2018R1A6A1A03025108"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejphar.2020.173532","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T16:29:09Z","timestamp":1598977749000},"page":"173532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Norquetiapine blocks the human cardiac sodium channel Nav1.5 in a state-dependent manner"],"prefix":"10.1016","volume":"885","author":[{"given":"Dong-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See-Hyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang June","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8439-6035","authenticated-orcid":false,"given":"Jin-Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173532_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.RES.79.1.103","article-title":"Lidocaine block of LQT-3 mutant human Na+ channels","volume":"79","author":"An","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173532_bib2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0026-895X(25)10504-X","article-title":"Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967)","volume":"48","author":"Bezprozvanny","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173532_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00002018-200023040-00003","article-title":"Quetiapine: a review of its safety in the management of schizophrenia","volume":"23","author":"Dev","year":"2000","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2020.173532_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine: an atypical antipsychotic","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2020.173532_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/FTD.0b013e3182603f62","article-title":"Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxyquetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors","volume":"34","author":"Fisher","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2020.173532_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-642-25761-2_2","article-title":"Role of dopamine D(2) receptors for antipsychotic activity","author":"Ginovart","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173532_bib7","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173532_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","article-title":"The hERG potassium channel and hERG screening for drug-induced torsades de pointes","volume":"119","author":"Hancox","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173532_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0000000000000075","article-title":"Quetiapine and the need for a thorough QT\/QTc study","volume":"34","author":"Hasnain","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173532_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/2045125313510194","article-title":"Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports","volume":"4","author":"Hasnain","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.ejphar.2020.173532_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ejhg.2012.63","article-title":"Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation","volume":"20","author":"Hong","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2020.173532_bib12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1517\/14656566.2012.681377","article-title":"Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy","volume":"13","author":"Janicak","year":"2012","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2020.173532_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2016.09.115","article-title":"Trifluoperazine blocks the human cardiac sodium channel, Nav1.5, independent of calmodulin","volume":"479","author":"Kim","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2020.173532_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","article-title":"A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs","volume":"450","author":"Kongsamut","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173532_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neulet.2017.11.029","article-title":"Effects of norquetiapine, the active metabolite of quetiapine, on cloned hERG potassium channels","volume":"664","author":"Lee","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.173532_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fpsyt.2013.00102","article-title":"Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders","volume":"4","author":"Lopez-Munoz","year":"2013","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173532_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tcm.2015.05.006","article-title":"Late sodium current: a mechanism for angina, heart failure, and arrhythmia","volume":"26","author":"Makielski","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2020.173532_bib18","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/mol.54.6.1080","article-title":"Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons","volume":"54","author":"McDonough","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173532_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/JCP.0b013e3181f2288e","article-title":"Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF","volume":"30","author":"Nikisch","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Suppl. 4","key":"10.1016\/j.ejphar.2020.173532_bib20","article-title":"Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload","volume":"92","author":"Noble","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2020.173532_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejphar.2020.173532_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/cpt.250","article-title":"Hazell on Behalf of Investigators of the Aritmo Consortium, L., Investigators of the, A.C., Sudden cardiac and sudden unexpected death related to antipsychotics: a meta-analysis of observational studies","volume":"99","author":"Salvo","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173532_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173532_bib24","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0024-3205(95)00210-W","article-title":"The role of 5-HT2A receptors in antipsychotic activity","volume":"56","author":"Schmidt","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173532_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tcm.2010.03.002","article-title":"Sodium channel molecular conformations and antiarrhythmic drug affinity","volume":"20","author":"Sheets","year":"2010","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2020.173532_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archpsyc.1997.01830180067009","article-title":"Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group","volume":"54","author":"Small","year":"1997","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173532_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/geno.1996.0236","article-title":"Genomic organization of the human SCN5A gene encoding the cardiac sodium channel","volume":"34","author":"Wang","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.ejphar.2020.173532_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(01)03320-8","article-title":"Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents","volume":"512","author":"Witchel","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2020.173532_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1568026054367584","article-title":"Voltage-gated sodium channel blockers; target validation and therapeutic potential","volume":"5","author":"Wood","year":"2005","journal-title":"Curr. Top. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920306245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920306245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:41:06Z","timestamp":1757976066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920306245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":29,"alternative-id":["S0014299920306245"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173532","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Norquetiapine blocks the human cardiac sodium channel Nav1.5 in a state-dependent manner","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173532"}}